Huan Xu, PhD, MD.
Shanghai 9th People’s Hospital, Shanghai Jiaotong University
Urology Department, Resident, Surgeon.
Huan Xu mainly focuses on the study of metabolic reprogramming in prostate cancer, having recently carried out research on the fatty acid elongation process in prostate cancer, and detected the serum lipid metabolic profiling in prostate cancer patients. Dr. Xu also studies the lineage switch in prostate cells in metabolic reprogramming pathways, which might be a new candidate for the treatment of benign prostate hyperplasia or lethal prostate cancer.
Huan Xu, PhD, MD.
Shanghai 9th People’s Hospital, Shanghai Jiaotong University
Urology Department, Resident, Surgeon.
Huan Xu mainly focuses on the study of metabolic reprogramming in prostate cancer, having recently carried out research on the fatty acid elongation process in prostate cancer, and detected the serum lipid metabolic profiling in prostate cancer patients. Dr. Xu also studies the lineage switch in prostate cells in metabolic reprogramming pathways, which might be a new candidate for the treatment of benign prostate hyperplasia or lethal prostate cancer.